Merck & Co., Inc. (MRK)

Basic

  • Market Cap

    $262.17B

  • EV

    $288.32B

  • Shares Out

    2,534.02M

  • Revenue

    $59.32B

  • Employees

    68,000

Margins

  • Gross

    73.09%

  • EBITDA

    21.81%

  • Operating

    15.57%

  • Pre-Tax

    12.56%

  • Net

    7.77%

  • FCF

    22.2%

Returns (5Yr Avg)

  • ROA

    8.33%

  • ROE

    32.08%

  • ROCE

    17.77%

  • ROIC

    14.08%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $123.61

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $23.38

  • Earnings (Dil)

    $1.8

  • FCF

    $5.17

  • Book Value

    $16.27

Growth (CAGR)

  • Rev 3Yr

    11.81%

  • Rev 5Yr

    7.29%

  • Rev 10Yr

    2.93%

  • Dil EPS 3Yr

    -21.55%

  • Dil EPS 5Yr

    7.82%

  • Dil EPS 10Yr

    1.93%

  • Rev Fwd 2Yr

    3.11%

  • EBITDA Fwd 2Yr

    7.23%

  • EPS Fwd 2Yr

    6.25%

  • EPS LT Growth Est

    14.43%

Dividends

  • Yield

    —

  • Payout

    158.58%

  • DPS

    $2.88

  • DPS Growth 3Yr

    6.56%

  • DPS Growth 5Yr

    8.56%

  • DPS Growth 10Yr

    5.35%

  • DPS Growth Fwd 2Yr

    7.55%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

42,294.0

39,121.0

41,518.0

48,704.0

59,283.0

59,315.0

Total Revenues % Chg.

5.4%

-7.5%

6.1%

17.3%

21.7%

0.6%

Cost of Goods Sold, Total

13,351.0

11,060.0

11,990.0

13,501.0

17,206.0

15,963.0

Gross Profit

28,943.0

28,061.0

29,528.0

35,203.0

42,077.0

43,352.0

Selling General & Admin Expenses, Total

9,587.0

8,829.0

8,569.0

9,403.0

9,669.0

10,226.0

R&D Expenses

9,254.0

8,594.0

13,224.0

11,907.0

11,843.0

23,890.0

Other Operating Expenses, Total

18,841.0

17,423.0

21,793.0

21,310.0

21,512.0

34,116.0

Operating Income

10,102.0

10,638.0

7,735.0

13,893.0

20,565.0

9,236.0

Interest Expense, Total

-772.0

-893.0

-831.0

-806.0

-962.0

-1,071.0

Interest And Investment Income

343.0

274.0

118.0

72.0

314.0

547.0

Net Interest Expenses

-429.0

-619.0

-713.0

-734.0

-648.0

-524.0

Income (Loss) On Equity Invest.

—

—

—

—

—

—

Currency Exchange Gains (Loss)

-145.0

-187.0

-145.0

-297.0

-237.0

-225.0

Other Non Operating Income (Expenses)

111.0

124.0

71.0

220.0

524.0

867.0

EBT, Excl. Unusual Items

9,639.0

9,956.0

6,948.0

13,082.0

20,204.0

9,354.0

Restructuring Charges

-658.0

-915.0

-705.0

-868.0

-666.0

-639.0

Merger & Related Restructuring Charges

-344.0

-1,745.0

-1,628.0

—

—

—

Impairment of Goodwill

-144.0

-162.0

—

—

—

—

Gain (Loss) On Sale Of Investments

283.0

170.0

1,338.0

1,940.0

-1,419.0

182.0

Gain (Loss) On Sale Of Assets

—

—

—

—

—

-37.0

Asset Writedown

-289.0

-172.0

-90.0

-275.0

-1,600.0

-713.0

In Process R&D Expenses

—

—

—

—

—

—

Legal Settlements

115.0

—

—

—

—

-573.0

Other Unusual Items

99.0

39.0

—

—

-75.0

-126.0

EBT, Incl. Unusual Items

8,701.0

7,171.0

5,863.0

13,879.0

16,444.0

7,448.0

Income Tax Expense

2,508.0

1,565.0

1,340.0

1,521.0

1,918.0

2,827.0

Earnings From Continuing Operations

6,193.0

5,606.0

4,523.0

12,358.0

14,526.0

4,621.0

Earnings Of Discontinued Operations

—

4,153.0

2,548.0

704.0

—

—

Minority Interest

27.0

84.0

-4.0

-13.0

-7.0

-13.0

Net Income

6,220.0

9,843.0

7,067.0

13,049.0

14,519.0

4,608.0

Net Income to Common Incl Extra Items

6,220.0

9,843.0

7,067.0

13,049.0

14,519.0

4,608.0

Net Income to Common Excl. Extra Items

6,220.0

5,690.0

4,519.0

12,345.0

14,519.0

4,608.0

Total Shares Outstanding

2,592.6

2,539.0

2,530.2

2,527.6

2,537.8

2,535.3

Weighted Avg. Shares Outstanding

2,664.0

2,565.0

2,530.0

2,530.0

2,532.0

2,537.3

Weighted Avg. Shares Outstanding Dil

2,679.0

2,580.0

2,541.0

2,538.0

2,542.0

2,548.8

EPS

2.3

3.8

2.8

5.2

5.7

1.8

EPS Diluted

2.3

3.8

2.8

5.1

5.7

1.8

EBITDA

14,622.0

13,715.0

10,953.0

17,016.0

24,354.0

12,934.0